Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ceftazidime (500mg) + Tobramycin (60mg) Injection
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Injection
Packaging Type
Vial
Packaging
560mg
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Dimezeft TZ 560 Injection containing Ceftazidime and Tobramycin is used for the management of moderate to severe bacterial infections. It provides broad-spectrum antibacterial coverage and supports effective infection control.
Ceftazidime works as a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, while Tobramycin is an aminoglycoside that inhibits bacterial protein synthesis, together enhancing antibacterial efficacy.
The injection is widely used in hospital and critical care settings for respiratory, urinary tract, intra-abdominal, and complicated systemic infections, leading to consistent institutional demand.
With increasing prevalence of resistant bacterial infections and growing need for combination antibiotic therapies, this product offers strong business potential for retailers and distributors. Its dual-action antimicrobial synergy, broad clinical relevance, and steady market demand make it a reliable product for growth in the critical care antibiotic segment.
Some patients may experience injection site pain, nausea, diarrhea, dizziness, rash, or headache. Rarely, kidney toxicity, hearing impairment (ototoxicity), or severe allergic reactions may occur and require immediate medical attention.
Dimezeft TZ 560 Injection is indicated for severe respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, septicemia, and hospital-acquired infections caused by susceptible organisms. It helps control resistant bacterial infections and supports recovery in critical cases.
This injection should be administered strictly under medical supervision by qualified healthcare professionals. Kidney function monitoring is recommended during treatment. Complete the full prescribed course to prevent antibiotic resistance.
Store below 25°C, protected from moisture and direct sunlight. Keep the vial in its original packaging and out of reach of children.
Composition : Amoxycillin (250mg)
Composition : Amoxycillin I.P. 250mg + 1.66 Millions Lactic Acid Bacillus
Composition : Amoxycillin (500mg)
Composition : Amoxycillin (500mg) + Lactic Acid Bacillus (1.66 Millions)
Composition : Amoxycillin Trihydrate I.P. 250mg + Cloxacillin I.P. 250mg + Lactic Acid Bacillus 1.7 Billion Spores
Composition : Amoxycillin (1000mg) + Clavulanic Acid (200mg)
Composition : Amoxycillin (125mg) + Clavulanic Acid (25mg)
Composition : Amoxycillin (250mg) + Clavulanic Acid (50mg)
Composition : Amoxycillin (500mg) + Clavulanic Acid (100mg)
Composition : Amoxycillin (500mg) + Clavulanic Acid (125mg) + Lactobacillus
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ceftazidime 500mg + Tobramycin 60mg Injection has strong demand in the hospital, critical-care, and anti-infective segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on injectable antibiotic portfolios.
Medical distributors and agencies can benefit from consistent demand for serious bacterial infection management under strict medical supervision. Ceftazidime 500mg is a third-generation cephalosporin antibiotic with broad-spectrum antibacterial activity, including activity against many gram-negative organisms Tobramycin 60mg is an aminoglycoside antibiotic effective against susceptible gram-negative bacteria Commonly used for respiratory tract infections, urinary tract infections, intra-abdominal infections, septicemia, and other serious hospital-acquired infections as prescribed by specialists Provides broad antibacterial coverage for the management of complicated infections Widely used in ICUs, surgical wards, emergency departments, and tertiary care hospitals This strengthens a comprehensive critical-care and hospital anti-infective portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ceftazidime 500mg + Tobramycin 60mg Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong hospital demand, institutional procurement opportunities, specialist-driven prescriptions, repeat orders, and reliable supply chain support, along with attractive margins in the injectable antibiotic segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from professional marketing support, quality pharmaceutical products, and a dependable supply chain for long-term business growth.